Format

Send to

Choose Destination
Heart. 2018 Jul;104(13):1135-1136. doi: 10.1136/heartjnl-2018-313168.

Non-vitamin K antagonist oral anticoagulants and infective endocarditis.

Author information

1
Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
2
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
3
Serviço de Cardiologia, Hospital Universitário de Santa Maria, CAML, Centro Cardiovascular da Universidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

KEYWORDS:

cardiac surgery; endocarditis; neurologic events; pharmacology; stroke

PMID:
29895673
DOI:
10.1136/heartjnl-2018-313168
[Indexed for MEDLINE]

Conflict of interest statement

Competing interests: JJF had speaker and consultant fees with GlaxoSmithKline, Novartis, TEVA, Lundbeck, Solvay, Abbott, Bial, Merck-Serono, Grunenthal and Merck Sharp and Dohme. FJP had consultant and speaker fees with Astra Zeneca, Bayer, Boehringer Ingelheim, and Daiichi Sankyo. DC and JC do not have any competing interests to disclose.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center